Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2017;2(1):1357.DOI: 10.25107/2474-1663-v2-id1357

Effects of Vialinins A and B on Murine Splenocytes Sensitized with Ovalbumin

Jun-ichi Onose, Fumiyo Sekiya, Aki Shiomitsu, Yasukiyo Yoshioka, Kouichi Sugaya and Naoki Abe

Department of Nutritional Science and Food Safety, Faculty of Applied Bio-science, Tokyo University of Agriculture, Japan

*Correspondance to: Naoki Abe 

 PDF  Full Text Research Article | Open Access

Abstract:

Vialinins A and B, as strong inhibitors of the production and release of tumor necrosis factor (TNF)-α, have been isolated from the edible Chinese mush room, Thelephoravialis. Here we investigated the inhibitory effects of vialinins A and B on the immune system. Splenocytes obtained from ovalbumin (OVA)-sensitized BALB/c mice were challenged with OVA in the presence of vialinins A and B, and cytokine levels in the medium of cultured cells were measured. Vialinins A and B inhibited production of OVA-specific immunoglobulin (Ig)E and Th2-type cytokines (interleukin (IL)-4, IL-5, and IL-10) but not production ofTh1-type cytokines (interferon-γ, IL-2, and IL-12). Flow cytometric assay showed a significantly higher percentage of regulatory T cells (CD25- and Foxp3-positive T cells) among splenocytes cultured with OVA and vialinins A and B than among those cultured with OVA alone. This offers a first demonstration that vialinins A and B inhibit antigen-specific IgE- and Th2-type cytokines and regulation of regulatory T cells, suggesting the utility of vialinins A and B in preventing deleterious immune responses.

Keywords:

Cite the Article:

Jun-ichi Onose, Sekiya F, Shiomitsu A, Yoshioka Y, Sugaya K, Abe N. Effects of Vialinins A and B on Murine Splenocytes Sensitized with Ovalbumin. Clin Oncol. 2017; 2: 1357.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Pediatric Cancer Predisposition Documentation Tool - Standardized Reporting Form for Children and Adolescents with Suspected Cancer Predisposition Syndrome
 Abstract  PDF  Full Text
Dysregulated Circadian Clock and Aged Stem Cell: An Inflammatory Crosstalk?
 PDF  Full Text
View More...